Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Proteomic Workflows for High-Quality Quantitative Proteome and Post-Translational Modification Analysis of Clinically Relevant Samples from Formalin-Fixed Paraffin-Embedded Archives.
Kuras M, Woldmar N, Kim Y, Hefner M, Malm J, Moldvay J, Döme B, Fillinger J, Pizzatti L, Gil J, Marko-Varga G, Rezeli M. Kuras M, et al. Among authors: moldvay j. J Proteome Res. 2021 Jan 1;20(1):1027-1039. doi: 10.1021/acs.jproteome.0c00850. Epub 2020 Dec 10. J Proteome Res. 2021. PMID: 33301673
Significant changes in advanced lung cancer survival during the past decade in Hungary: impact of modern immunotherapy and the COVID-19 pandemic.
Kiss Z, Gálffy G, Müller V, Moldvay J, Sárosi V, Pápai-Székely Z, Csada E, Kerpel-Fronius A, Király Z, Szász Z, Hódi G, Polányi Z, Kovács K, Karamousouli E, Knollmajer K, Szabó TG, Berta A, Vokó Z, Rokszin G, Abonyi-Tóth Z, Barcza Z, Tamási L, Bogos K. Kiss Z, et al. Among authors: moldvay j. Front Oncol. 2023 Oct 4;13:1207295. doi: 10.3389/fonc.2023.1207295. eCollection 2023. Front Oncol. 2023. PMID: 37860193 Free PMC article.
Reply to Rare Versus Artifactual EGFR Mutations.
Lohinai Z, Ostoros G, Moldvay J, Dome B, Hegedus B. Lohinai Z, et al. Among authors: moldvay j. J Thorac Oncol. 2015 Aug;10(8):e80-1. doi: 10.1097/JTO.0000000000000591. J Thorac Oncol. 2015. PMID: 26200290 Free article. No abstract available.
KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS mutation and bone metastasis.
Lohinai Z, Klikovits T, Moldvay J, Ostoros G, Raso E, Timar J, Fabian K, Kovalszky I, Kenessey I, Aigner C, Renyi-Vamos F, Klepetko W, Dome B, Hegedus B. Lohinai Z, et al. Among authors: moldvay j. Sci Rep. 2017 Jan 4;7:39721. doi: 10.1038/srep39721. Sci Rep. 2017. PMID: 28051122 Free PMC article.
108 results